Skip to content
healthcare.dev

Insulin Degludec

NDC 73070-400, insulin degludec, injection, solution, from Novo Nordisk Pharma, Inc..

Product NDC
73070-400
Status
Listed
Labeler
Novo Nordisk Pharma, Inc.
Dosage form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA203314
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/73070-400 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • INSULIN DEGLUDEC100 U/mL

Pharmacologic classes

Insulin Analog [EPC]; Insulin [CS]

Package NDCNDC-11Package
73070-400-11730700400111 VIAL, GLASS in 1 CARTON (73070-400-11) / 10 mL in 1 VIAL, GLASS

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/c1be283d-4b1d-4996-b2a7-4488dbff3037
  • NADAC price for package 73070040011

    GET /v1/drugs/nadac/73070040011

Use it

Look up 73070-400 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/73070-400 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 73070-400. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.